List of Contents

Psoriatic Arthritis Treatment Market Size, Share, and Trends 2024 to 2034

Psoriatic Arthritis Treatment Market (By Drug Class: Non-steroidal Anti-inflammatory Drugs (NSAIDs), Non-biologics Disease-modifying Anti-rheumatic Drugs (DMARDs), Biologics Disease-modifying Anti-rheumatic Drugs, Others; By Product Type: Prescriptions, OTC; By Route of Administration: Topical, Oral, Injectable) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034

  • Last Updated : July 2024
  • Report Code : 4700
  • Category : Healthcare

1. Executive Summary

  • Overview of the Psoriatic Arthritis Treatment Market
  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
    • Challenges

2. Market Overview

  • Definition and Scope
  • Market Segmentation
  • Key Market Trends
  • Market Forecast and Analysis

3. Market Dynamics

  • Drivers and Restraints
  • Opportunities and Challenges
  • Market Trends and Developments

4. Industry Insights

  • Market Landscape
  • Key Regulations and Policies
  • Competitive Landscape
    • Market Share Analysis
    • Key Developments and Innovations

5. Psoriatic Arthritis Treatment Market Segmentation Analysis

By Drug Class

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
    • Market Trends
    • Key Players
    • Product Innovations
  • Non-biologics Disease-modifying Anti-rheumatic Drugs (DMARDs)
    • Market Trends
    • Key Players
    • Product Innovations
  • Biologics Disease-modifying Anti-rheumatic Drugs
    • Market Trends
    • Key Players
    • Product Innovations
  • Others
    • Market Trends
    • Key Players
    • Product Innovations

By Product Type

  • Prescriptions
    • Market Trends
    • Key Players
    • Product Innovations
  • Over-the-Counter (OTC)
    • Market Trends
    • Key Players
    • Product Innovations

By Route of Administration

  • Topical
    • Market Trends
    • Key Players
    • Product Innovations
  • Oral
    • Market Trends
    • Key Players
    • Product Innovations
  • Injectable
    • Market Trends
    • Key Players
    • Product Innovations

By Geography

  • North America
    • Market Trends
    • Key Players
    • Regional Insights
  • Asia Pacific
    • Market Trends
    • Key Players
    • Regional Insights
  • Europe
    • Market Trends
    • Key Players
    • Regional Insights
  • Latin America
    • Market Trends
    • Key Players
    • Regional Insights
  • Middle East & Africa
    • Market Trends
    • Key Players
    • Regional Insights

6. Cross-sectional Analysis

By Drug Class

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
    • Product Type
      • Prescriptions
      • OTC
    • Route of Administration
      • Topical
      • Oral
      • Injectable
    • Geography
      • North America
      • Asia Pacific
      • Europe
      • Latin America
      • Middle East & Africa
  • Non-biologics Disease-modifying Anti-rheumatic Drugs (DMARDs)
    • Product Type
      • Prescriptions
      • OTC
    • Route of Administration
      • Topical
      • Oral
      • Injectable
    • Geography
      • North America
      • Asia Pacific
      • Europe
      • Latin America
      • Middle East & Africa
  • Biologics Disease-modifying Anti-rheumatic Drugs
    • Product Type
      • Prescriptions
      • OTC
    • Route of Administration
      • Topical
      • Oral
      • Injectable
    • Geography
      • North America
      • Asia Pacific
      • Europe
      • Latin America
      • Middle East & Africa
  • Others
    • Product Type
      • Prescriptions
      • OTC
    • Route of Administration
      • Topical
      • Oral
      • Injectable
    • Geography
      • North America
      • Asia Pacific
      • Europe
      • Latin America
      • Middle East & Africa

By Product Type

  • Prescriptions
    • Drug Class
      • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
      • Non-biologics Disease-modifying Anti-rheumatic Drugs (DMARDs)
      • Biologics Disease-modifying Anti-rheumatic Drugs
      • Others
    • Route of Administration
      • Topical
      • Oral
      • Injectable
    • Geography
      • North America
      • Asia Pacific
      • Europe
      • Latin America
      • Middle East & Africa
  • OTC
    • Drug Class
      • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
      • Non-biologics Disease-modifying Anti-rheumatic Drugs (DMARDs)
      • Biologics Disease-modifying Anti-rheumatic Drugs
      • Others
    • Route of Administration
      • Topical
      • Oral
      • Injectable
    • Geography
      • North America
      • Asia Pacific
      • Europe
      • Latin America
      • Middle East & Africa

By Route of Administration

  • Topical
    • Drug Class
      • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
      • Non-biologics Disease-modifying Anti-rheumatic Drugs (DMARDs)
      • Biologics Disease-modifying Anti-rheumatic Drugs
      • Others
    • Product Type
      • Prescriptions
      • OTC
    • Geography
      • North America
      • Asia Pacific
      • Europe
      • Latin America
      • Middle East & Africa
  • Oral
    • Drug Class
      • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
      • Non-biologics Disease-modifying Anti-rheumatic Drugs (DMARDs)
      • Biologics Disease-modifying Anti-rheumatic Drugs
      • Others
    • Product Type
      • Prescriptions
      • OTC
    • Geography
      • North America
      • Asia Pacific
      • Europe
      • Latin America
      • Middle East & Africa
  • Injectable
    • Drug Class
      • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
      • Non-biologics Disease-modifying Anti-rheumatic Drugs (DMARDs)
      • Biologics Disease-modifying Anti-rheumatic Drugs
      • Others
    • Product Type
      • Prescriptions
      • OTC
    • Geography
      • North America
      • Asia Pacific
      • Europe
      • Latin America
      • Middle East & Africa

By Geography

  • North America
    • Drug Class
      • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
      • Non-biologics Disease-modifying Anti-rheumatic Drugs (DMARDs)
      • Biologics Disease-modifying Anti-rheumatic Drugs
      • Others
    • Product Type
      • Prescriptions
      • OTC
    • Route of Administration
      • Topical
      • Oral
      • Injectable
  • Asia Pacific
    • Drug Class
      • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
      • Non-biologics Disease-modifying Anti-rheumatic Drugs (DMARDs)
      • Biologics Disease-modifying Anti-rheumatic Drugs
      • Others
    • Product Type
      • Prescriptions
      • OTC
    • Route of Administration
      • Topical
      • Oral
      • Injectable
  • Europe
    • Drug Class
      • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
      • Non-biologics Disease-modifying Anti-rheumatic Drugs (DMARDs)
      • Biologics Disease-modifying Anti-rheumatic Drugs
      • Others
    • Product Type
      • Prescriptions
      • OTC
    • Route of Administration
      • Topical
      • Oral
      • Injectable
  • Latin America
    • Drug Class
      • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
      • Non-biologics Disease-modifying Anti-rheumatic Drugs (DMARDs)
      • Biologics Disease-modifying Anti-rheumatic Drugs
      • Others
    • Product Type
      • Prescriptions
      • OTC
    • Route of Administration
      • Topical
      • Oral
      • Injectable
  • Middle East & Africa
    • Drug Class
      • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
      • Non-biologics Disease-modifying Anti-rheumatic Drugs (DMARDs)
      • Biologics Disease-modifying Anti-rheumatic Drugs
      • Others
    • Product Type
      • Prescriptions
      • OTC
    • Route of Administration
      • Topical
      • Oral
      • Injectable

7. Go-to-Market Strategies

  • Market Entry Strategies
    • Analysis of Entry Modes: Direct Investment, Joint Ventures, Strategic Alliances
    • Country-Specific Market Entry Strategies
    • Risk Assessment and Mitigation
  • Pricing Strategies
    • Pricing Models: Cost-Based, Value-Based, Competitive Pricing
    • Price Sensitivity Analysis
    • Discounts, Rebates, and Incentives
  • Distribution Channels
    • Direct vs. Indirect Distribution
    • Channel Partners and Intermediaries
    • E-commerce and Online Sales Channels
  • Promotion and Branding Strategies
    • Advertising and Media Plans
    • Public Relations and Media Coverage
    • Digital Marketing and Social Media Strategies
    • Brand Positioning and Messaging

8. Competition Analysis

  • Key Market Players
    • Profiles of Major Companies
    • Product Portfolio and Market Share
    • Recent Developments and Strategic Moves
  • Market Share Analysis
    • Market Share Distribution
    • Historical and Projected Market Share Trends
  • Competitive Landscape
    • Market Structure and Competitive Intensity
    • Analysis of Competitive Strategies
    • Benchmarking Against Industry Standards
  • SWOT Analysis of Major Competitors
    • Strengths, Weaknesses, Opportunities, and Threats
  • Strategic Initiatives and Partnerships
    • Recent Partnerships and Collaborations
    • Mergers and Acquisitions
    • Strategic Alliances and Joint Ventures

9. Opportunity Assessment

  • Market Segmentation Analysis
    • Segmentation by Drug Type, Treatment Approach, and Patient Demographics
    • Segment Analysis: Size, Growth Rate, and Trends
  • Emerging Market Opportunities
    • Identification of High-Growth Areas
    • Unmet Needs and Market Gaps
  • Market Drivers and Challenges
    • Key Drivers of Market Growth
    • Challenges and Barriers to Entry
  • Growth Potential by Region
    • Regional Market Analysis
    • Growth Opportunities in Key Regions
  • Investment Opportunities
    • Investment Potential in Emerging Markets
    • Risk and Return Analysis for Investors

10. Supply Chain Intelligence/Streamline Operations

  • Supply Chain Overview
    • End-to-End Supply Chain Structure
    • Key Processes and Operations
  • Key Suppliers and Distributors
    • Major Suppliers and Their Capabilities
    • Distribution Networks and Key Players
  • Logistics and Distribution Channels
    • Logistics Management Strategies
    • Distribution Efficiency and Optimization
  • Inventory Management
    • Inventory Control Techniques
    • Demand Forecasting and Supply Planning
  • Challenges and Solutions in Supply Chain Management
    • Common Supply Chain Challenges
    • Strategies for Addressing Supply Chain Issues
    • Case Studies of Effective Supply Chain Management

11. Cross-Border Intelligence

  • International Market Trends
    • Global Market Trends and Dynamics
    • Impact of Global Economic Conditions
  • Regulatory and Compliance Issues
    • Key Regulatory Requirements by Region
    • Compliance Challenges and Solutions
  • Cross-Border Trade and Market Access
    • Trade Policies and Tariffs
    • Market Access Strategies
  • Regional Market Dynamics
    • Market Conditions in Key Regions
    • Regional Competitive Landscape
  • Cultural and Economic Factors
    • Cultural Influences on Market Preferences
    • Economic Factors Affecting Market Demand

12. Business Model Innovation

  • Traditional vs. Innovative Business Models
    • Comparison of Conventional and Modern Business Models
    • Case Studies of Innovative Models in the Healthcare Sector
  • Case Studies of Successful Innovations
    • Examples of Disruptive Innovations
    • Impact of Innovations on Market Dynamics
  • Revenue Streams and Profitability
    • Analysis of Revenue Models
    • Profitability Trends and Forecasts
  • Digital Transformation and Technology Integration
    • Role of Digital Technologies
    • Case Studies of Digital Transformation

13. Blue Ocean vs. Red Ocean Strategies

  • Definitions and Concepts
    • Overview of Blue Ocean and Red Ocean Strategies
    • Strategic Differences and Applications
  • Application in Psoriatic Arthritis Treatment Market
    • Examples of Blue Ocean Strategies in the Market
    • Red Ocean Strategies and Competitive Tactics
  • Case Studies of Blue Ocean Strategies
    • Success Stories and Lessons Learned
  • Competitive Strategies in Red Oceans
    • Analysis of Competitive Strategies in Saturated Markets
  • Risk and Reward Analysis
    • Risk Assessment for Blue Ocean Strategies
    • Reward Potential and Market Impact

14. Integration of AI in the Psoriatic Arthritis Treatment Market

  • Overview of AI Technologies
    • Description of Key AI Technologies and Tools
    • AI Trends in Healthcare
  • Applications of AI
    • Smart Tracking and Inventory Management
      • AI Solutions for Inventory Tracking
      • Benefits of AI in Inventory Management
    • Predictive Maintenance and Quality Control
      • AI for Predictive Maintenance
      • AI-Driven Quality Control Processes
    • Optimization of Supply Chain Logistics
      • AI for Supply Chain Optimization
      • Case Studies of AI in Logistics
  • Benefits of AI Integration
    • Enhanced Efficiency and Productivity
      • Improvements in Operational Efficiency
      • Productivity Gains from AI Integration
    • Cost Savings and Waste Reduction
      • Cost Reduction through AI Technologies
      • Waste Management and Efficiency
    • Improved Sustainability
      • Environmental Benefits of AI
      • Sustainability Initiatives Enabled by AI
  • Challenges and Considerations
    • Technical and Ethical Challenges
    • Implementation Considerations and Best Practices
  • Case Studies and Examples
    • Real-World Examples of AI Integration
    • Success Stories and Lessons Learned

15. Future Prospects and Innovations

  • Emerging Trends in Psoriatic Arthritis Treatment
    • Latest Trends and Developments
    • Impact of Emerging Trends on Market Dynamics
  • Technological Advancements
    • Overview of New Technologies
    • Potential Impact on Treatment Approaches
  • Potential Market Disruptors
    • Identification of Potential Disruptive Factors
    • Analysis of Disruption Risks and Opportunities
  • Strategic Recommendations
    • Actionable Recommendations for Stakeholders
    • Strategic Planning for Future Growth
  • Forecast and Future Outlook
    • Market Projections and Growth Forecasts
    • Long-Term Market Trends and Predictions

16. Company Profiles

  • AbbVie Inc.
    • Company Overview
    • Product Portfolio
    • Financials
    • Recent Developments
  • Janssen Global Services, LLC (Johnson & Johnson)
    • Company Overview
    • Product Portfolio
    • Financials
    • Recent Developments
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financials
    • Recent Developments
  • Amgen Inc.
    • Company Overview
    • Product Portfolio
    • Financials
    • Recent Developments
  • Biogen Inc.
    • Company Overview
    • Product Portfolio
    • Financials
    • Recent Developments
  • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financials
    • Recent Developments
  • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Financials
    • Recent Developments
  • UCB S.A.
    • Company Overview
    • Product Portfolio
    • Financials
    • Recent Developments
  • Bristol-Myers Squibb Company
    • Company Overview
    • Product Portfolio
    • Financials
    • Recent Developments
  • Merck & Co. Inc.
    • Company Overview
    • Product Portfolio
    • Financials
    • Recent Developments

17. Strategic Recommendations

  • Market Entry Strategies
  • Strategic Partnerships and Alliances
  • Mergers and Acquisitions

18. Future Outlook and Forecast

  • Market Forecast by Drug Class
  • Market Forecast by Product Type
  • Market Forecast by Route of Administration
  • Market Forecast by Geography

19. Appendices

 

  • Methodology
  • Data Sources
  • Glossary of Terms
  • Contact Information

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client